NAMSA Deploys TrackWise Software as its Quality Management System
Holmdel, NJ – September 11, 2007 –Sparta Systems, Inc. Sparta Systems, Inc. (Sparta), the maker of TrackWise®, and the market leader in enterprise quality and compliance management software, today announced that NAMSA, the world's leading company specializing in the safety evaluation of medical devices, deployed TrackWise to lower compliance risks and improve operational control. The go-live implementation, including validation, was completed within six months.
NAMSA deployed TrackWise to manage all aspects of its quality management applications including Nonconformance, Good Laboratory Practices (GLP), Complaint Handling, Corrective and Preventive Actions (CAPA), Audit Findings and Risk Assessments.
TrackWise is a configurable, web-based software management tool for electronically managing, tracking and trending quality, regulatory and organizational compliance processes. TrackWise enables companies to reduce costs and streamline business operations by replacing disparate systems and inefficient paper-based processes with a centralized electronic workflow and reporting system.
"At NAMSA, we understand the complex compliance requirements of the industry and we were looking for a centralized solution that would handle all of our NCR, CAPA and quality management needs,” said Michael Oberle, Director of Quality Assurance at NAMSA. “After examining several Quality Management Systems we chose Sparta Systems’ TrackWise due to its flexibility. TrackWise was flexible and scalable enough to handle eleven different process areas within our organization. The solution’s rapid application deployment quickly provided us with centralized and consolidated tracking, workflow management, and reporting for our critical business processes."
"NAMSA operates in a highly regulated arena, supporting the medical device and pharmaceutical industries through extensive testing services to ensure quality and compliance. TrackWise provided a centralized quality management solution with minimal configuration, reducing operational and compliance risks while streamlining operations," stated Ran Flam, President & CEO at Sparta Systems.
Error processing SSI fileAbout NAMSA
NAMSA is a multinational company with laboratories in the United States and France. NAMSA serves the health care industry by offering testing services to device manufacturers, raw material suppliers, pharmaceutical and biotech companies, sterilizers and other related industries.
The U.S.A. laboratories are certified to ISO 13485 and Biomatech, in France, is accredited according to ISO 17025. NAMSA also manufactures sterility assurance products such as biological indicators, growth promotion test suspensions, and chemical process indicators.
About Sparta Systems
Sparta Systems, Inc. is the industry leader for global quality and compliance management systems. Its TrackWise product is a web-based software application used by quality, manufacturing, and regulatory affairs professionals to manage quality and compliance issues across the enterprise. The company has more than 12 years of experience and an extensive customer base in the life sciences and other highly regulated industries. Sparta Systems offers its customers a complete solution for global quality management needs, including the onsite support required throughout the project lifecycle. More information about Sparta Systems and TrackWise® can be found at www.sparta-systems.com.
Media Contact: Jon RabinowitzDirector of Marketing
Sparta Systems, Inc.
Phone: (732) 203-0400 x121
Email: jon.rabinowitz@sparta-systems.com
Sparta Systems Inc. and the Sparta Systems, Inc. logo, TrackWise and the TrackWise logo are trademarks or registered trademarks of Sparta Systems, Inc.
All other company and product names are used for identification purposes only and may be trademarks of their respective owners. Sparta Systems, Inc. cannot guarantee completion of any of the aforementioned products or product features, and no reliance should be placed on their availability. Sparta Systems does not undertake an obligation to update the forward-looking information contained herein.